Cytokinetics continues to underperform Gilead by 33.3% in the past three months

Press/Media: Press / Media

Period2025 Apr 14

Media coverage

4

Media coverage

  • TitleCytokinetics continues to underperform Gilead by 33.3% in the past three months
    Media name/outletGlobal Round Up - Sectors
    Country/TerritoryUnited Kingdom
    Date25/4/14
    PersonsSung-Joon Lee
  • TitleCytokinetics continues to underperform Alnylam Pharmaceuticals by 9.3% in the past three months
    Media name/outletGlobal Round Up - Sectors
    Country/TerritoryUnited Kingdom
    Date25/4/14
    PersonsSung-Joon Lee
  • TitleCytokinetics continues to outperform Regeneron by 5.4% in the past three months
    Media name/outletGlobal Round Up - Sectors
    Country/TerritoryUnited Kingdom
    Date25/4/14
    PersonsSung-Joon Lee
  • TitleCytokinetics continues to underperform Amgen by 24.0% in the past three months
    Media name/outletGlobal Round Up - Sectors
    Country/TerritoryUnited Kingdom
    Date25/4/14
    PersonsSung-Joon Lee